AbbVie Aktie

192,26 EUR +1,78 EUR +0,93 %

15:43:30

STU

203,55 USD +2,61 USD +1,30 %

20:49:20

BTT

Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln!

JETZT LOSLEGEN

Du hast schon ein ZERO-Konto? Direkt handeln bei ZERO!Bei einem anderen Broker handeln Smartphone

Marktkap.338,61 Mrd. EUR

KGV74,34Div. Rendite3,54%

WKNA1J84E

ISINUS00287Y1091

SymbolABBV

AbbVie Aktien News

Sortieren:Datum Meistgelesen

08.05.24PR NewswireQULIPTA™ (atogepant) Now Approved by Health Canada for the Preventive Treatment of Chronic Migraine in Adults

06.05.24PR NewswireAbbVie to Present at the Bank of America Securities Healthcare Conference

05.05.24MotleyFool3 Reasons to Buy AbbVie Stock on the Dip

01.05.24ZacksHere is What to Know Beyond Why AbbVie Inc. (ABBV) is a Trending Stock

30.04.24ZacksAbbVie (ABBV) Could Be a Great Choice

29.04.24BenzingaPeeling Back The Layers: Exploring AbbVie Through Analyst Insights

28.04.24MotleyFoolBetter Dividend Stock: AbbVie or Johnson & Johnson?

26.04.24MotleyFoolWhy AbbVie Stock Stumbled Today Despite the Earnings Beat

26.04.24MotleyFoolAbbVie (ABBV) Q1 2024 Earnings Call Transcript

26.04.24ZacksAbbVie (ABBV) Beats on Q1 Earnings & Sales, Ups '24 EPS View

26.04.24ZacksAbbVie (ABBV) Reports Q1 Earnings: What Key Metrics Have to Say

26.04.24ZacksAbbVie (ABBV) Beats Q1 Earnings and Revenue Estimates

26.04.24PR NewswireAbbVie Reports First-Quarter 2024 Financial Results

25.04.24ZacksZacks Industry Outlook Highlights Eli Lilly, Novo Nordisk, Merck and AbbVie

25.04.24PR NewswireNew Data Show RINVOQ® (upadacitinib) Demonstrated Superiority Versus DUPIXENT® (dupilumab) Across Primary and All Secondary Endpoints in an Open-Label Head-to-Head Atopic Dermatitis Study

23.04.24ZacksGear Up for AbbVie (ABBV) Q1 Earnings: Wall Street Estimates for Key Metrics

22.04.24ZacksAbbVie (ABBV) to Report Q1 Earnings: What's in the Cards?

19.04.24ZacksEarnings Preview: AbbVie (ABBV) Q1 Earnings Expected to Decline

18.04.24PR NewswirePhase 3 SELECT-GCA Study of Upadacitinib (RINVOQ®) Showed Positive Results in Patients With Giant Cell Arteritis

17.04.24ZacksAbbVie (ABBV) Increases Despite Market Slip: Here's What You Need to Know

16.04.24ZacksAbbVie Inc. (ABBV) is Attracting Investor Attention: Here is What You Should Know

14.04.24MotleyFoolIs AbbVie a Millionaire Maker?

12.04.24BenzingaWhat's Going On AbbVie Stock On Friday?

12.04.24PR NewswireAbbVie Announces Late-Breaking Data at AAN Supporting Long-Term Safety and Efficacy of Atogepant (QULIPTA®) for Preventive Treatment of Migraine

11.04.24ZacksAbbVie (ABBV) Stock Declines While Market Improves: Some Information for Investors

10.04.24ZacksThe Zacks Analyst Blog Highlights AbbVie, Salesforce, General Electric, The TJX Companies and UBS Group

09.04.24ZacksTop Stock Reports for AbbVie, Salesforce & General Electric

09.04.24PR NewswireSkinMedica® Empowers Clear Skin Confidence with a New, Modern Approach to Acne

08.04.24ZacksHere's Why AbbVie (ABBV) Fell More Than Broader Market

05.04.24BenzingaAbbVie Unusual Options Activity For April 05

05.04.24ZacksAbbVie Inc. (ABBV) Is a Trending Stock: Facts to Know Before Betting on It

04.04.24PR NewswireAbbVie to Host First-Quarter 2024 Earnings Conference Call

03.04.24PR NewswireAllergan Aesthetics Announces the Return of CoolMonth with CoolSculpting®

01.04.24ZacksAbbVie (ABBV) Sees a More Significant Dip Than Broader Market: Some Facts to Know

27.03.24BenzingaHere's How Much You Would Have Made Owning AbbVie Stock In The Last 10 Years

26.03.24ZacksAbbVie (ABBV) to Buy Landos to Strengthen Autoimmune Portfolio

25.03.24ZacksAbbVie (ABBV) Advances While Market Declines: Some Information for Investors

25.03.24ZacksWhy AbbVie (ABBV) is a Great Dividend Stock Right Now

25.03.24PR NewswireAllergan Aesthetics Launches "Moving the Needle on Ethics" to Elevate the Conversation Around Ethics in Aesthetics

25.03.24ZacksInvestors Heavily Search AbbVie Inc. (ABBV): Here is What You Need to Know

AbbVie News

AbbVie News: auf dieser Seite finden Sie alle AbbVie News und Nachrichten zur AbbVie Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch AbbVie News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um AbbVie News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.